ADMINISTRATIVE CORE AND ENRICHMENT PROGRAM

行政核心和强化计划

基本信息

  • 批准号:
    7767531
  • 负责人:
  • 金额:
    $ 35.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-12-01 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

The Washington University DDRCC is integrated with the NIH's Clinical Translational Science Award (CTSA) sponsored Washington University Institute of Clinical Translational Sciences (ICTS), primarily through the Clinical Component ofthe DDRCC and the ICTS Centerfor Biomedical Informatics. The DDRCC Clinical Component is primarily focused on providing investigators with access to clinical samples for digestive diseases related research. The collection and maintenance of clinical samples linked to longitudinal clinical information in a manner that is responsive to our DDRCC investigators, requires a high level of clinical expertise in accurately phenotyping the patient subjects and a high level of stringent oversight in collecting clinical samples. For this reason, organization of tissue procurement at this institution has moved away from a single monolithic institutional unit attempting to collect a broad array of clinical samples from patients with many different diseases. Instead, tissue procurement is being conducted by smaller disease focused units, such as the DDRCC sponsored facility, that are linked to each other by a common biomedical informatics platforms (Tissue Suite and ClinPortal) developed and maintained by the CTSA-sponsored Center for Biomedical Informatics. Furthermore, the data output from two of the Research Core Facilities, the Functional Genomics Core and the Proteomics Core are in the process of being uploaded to databases (Profile DB) maintained by the ICTS Center for Biomedical Informatics.
华盛顿大学DDRCC与美国国立卫生研究院的临床转化科学奖相结合

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas O. Davidson其他文献

324 LIVER SPECIFIC DELETION OF TM6SF2 PROMOTES BOTH HEPATIC FIBROSIS AND HEPATOCELLULAR CANCER
  • DOI:
    10.1016/s0016-5085(20)33826-9
  • 发表时间:
    2020-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth P. Newberry;Zoe Hall;Yan Xie;Elizabeth A. Molitor;Elizabeth M. Brunt;Jules Griffin;Nicholas O. Davidson
  • 通讯作者:
    Nicholas O. Davidson
Tu1456: TAUROURSODEOXYCHOLIC ACID (TUDCA) REDUCES ER STRESS AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS: FINAL RESULTS OF A PHASE I TRIAL
  • DOI:
    10.1016/s0016-5085(22)62294-7
  • 发表时间:
    2022-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Vladimir Lamm;Ruishu Deng;Katherine Huang;Saeed Soleymanjahi;Ta-Chiang Liu;Yan Xie;Anas K. Gremida;Parakkal Deepak;Chien-Huan Chen;Nicholas O. Davidson;Miao Wang;Randal J. Kaufman;Matthew A. Ciorba
  • 通讯作者:
    Matthew A. Ciorba
466 GENETIC MODIFIERS OF VLDL SECRETION REGULATE HEPATOCELLULAR CANCER (HCC) DEVELOPMENT
  • DOI:
    10.1016/s0016-5085(24)04012-5
  • 发表时间:
    2024-05-18
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth P. Newberry;Saeed Soleymanjahi;Elizabeth A. Molitor;Xiuli Liu;Nicholas O. Davidson
  • 通讯作者:
    Nicholas O. Davidson
1289 RBM47 REGULATES FUNCTIONAL EXPRESSION OF NOVEL C-TO-U RNA EDITING TARGETS AND TUMORIGENESIS IN MOUSE AND HUMAN INTESTINE
  • DOI:
    10.1016/s0016-5085(24)01196-x
  • 发表时间:
    2024-05-18
  • 期刊:
  • 影响因子:
  • 作者:
    Valerie Blanc;Faisal Shurafa;Rebekah Greenspan;Elizabeth A. Molitor;Nicholas O. Davidson
  • 通讯作者:
    Nicholas O. Davidson
691 RNA BINDING PROTEIN APOBEC1 COMPLEMENTATION FACTOR (A1CF) ALTERS HEPATIC LIPOGENIC AND PROLIFERATIVE PATHWAYS PROMOTING SPONTANEOUS TUMORIGENESIS.
  • DOI:
    10.1016/s0016-5085(20)33879-8
  • 发表时间:
    2020-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Valerie Blanc;Yan Xie;Jesse Riordan;Joseph Nadeau;Ilke Nalbantoglu;Saeed Soleymanjahi;Blair Madison;Elizabeth M. Brunt;Elizabeth A. Molitor;Jason Mills;Irene O. Ng;Yeonjung Ha;Lewis R. Roberts;Nicholas O. Davidson
  • 通讯作者:
    Nicholas O. Davidson

Nicholas O. Davidson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas O. Davidson', 18)}}的其他基金

Intestinal Resection Associated Liver Injury and Fibrosis
小肠切除相关的肝损伤和纤维化
  • 批准号:
    10366528
  • 财政年份:
    2021
  • 资助金额:
    $ 35.57万
  • 项目类别:
Intestinal Resection Associated Liver Injury and Fibrosis
小肠切除相关的肝损伤和纤维化
  • 批准号:
    10492758
  • 财政年份:
    2021
  • 资助金额:
    $ 35.57万
  • 项目类别:
Impaired VLDL secretion, progression and reversal of hepatic fibrogenesis
VLDL 分泌受损、肝纤维化进展和逆转
  • 批准号:
    9978062
  • 财政年份:
    2019
  • 资助金额:
    $ 35.57万
  • 项目类别:
Impaired VLDL secretion, progression and reversal of hepatic fibrogenesis
VLDL 分泌受损、肝纤维化进展和逆转
  • 批准号:
    10396531
  • 财政年份:
    2019
  • 资助金额:
    $ 35.57万
  • 项目类别:
Bile acid metabolomics and metagenomics in short bowel syndrome
短肠综合征的胆汁酸代谢组学和宏基因组学
  • 批准号:
    9354486
  • 财政年份:
    2016
  • 资助金额:
    $ 35.57万
  • 项目类别:
Bile acid metabolomics and metagenomics in short bowel syndrome
短肠综合征的胆汁酸代谢组学和宏基因组学
  • 批准号:
    9248090
  • 财政年份:
    2016
  • 资助金额:
    $ 35.57万
  • 项目类别:
Hepatic Fatty Acid Metabolism and Steatosis
肝脏脂肪酸代谢和脂肪变性
  • 批准号:
    7861167
  • 财政年份:
    2009
  • 资助金额:
    $ 35.57万
  • 项目类别:
Molecul Biology of Intestinal Lipid Transport/Metabolism
肠道脂质运输/代谢的分子生物学
  • 批准号:
    6673433
  • 财政年份:
    2003
  • 资助金额:
    $ 35.57万
  • 项目类别:
Regulatory Factors in the GI Tract
胃肠道的调节因素
  • 批准号:
    8385588
  • 财政年份:
    2000
  • 资助金额:
    $ 35.57万
  • 项目类别:
REGULATORY FACTORS IN THE GI TRACT
胃肠道的调节因素
  • 批准号:
    7846282
  • 财政年份:
    2000
  • 资助金额:
    $ 35.57万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
  • 批准号:
    2734768
  • 财政年份:
    2026
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Studentship
Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
  • 批准号:
    ES/Z502431/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
  • 批准号:
    MR/Y009657/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Fellowship
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
  • 批准号:
    MR/Y013050/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Fellowship
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
  • 批准号:
    2412195
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Standard Grant
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
  • 批准号:
    MR/Y014707/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Research Grant
Determining the clinical utility of BioEP: a multisite, prospective, study
确定 BioEP 的临床效用:一项多中心前瞻性研究
  • 批准号:
    10090508
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Investment Accelerator
VITAL: VIrtual Twins as tools for personalised clinicAL care
VITAL:虚拟双胞胎作为个性化临床护理的工具
  • 批准号:
    10106393
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    EU-Funded
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
量子脑成像:临床应用的途径
  • 批准号:
    10107115
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Small Business Research Initiative
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
  • 批准号:
    10089281
  • 财政年份:
    2024
  • 资助金额:
    $ 35.57万
  • 项目类别:
    Investment Accelerator
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了